Acupuncture/electroacupuncture enhances antidepressant effect of seroxat: The symptom checklist-90 scores

Neural Regeneration Research

Volumn 9, Issue 2, 2014, Pages 213-222

  Chen, Jun Qi ^a   Lin, Wei Rong ^b   Wang, Sheng Xu ^c   Wang, Chong Qi ^c   Li, Gan Long ^a   Qu, Shan Shan ^c   Huang, Yong ^c   Zhang, Zhang Jin ^d   Xiao, Wei ^c  

^a THE THIRD AFFILIATED HOSPITAL OF SOUTHERN MEDICAL UNIVERSITY   (China)

^b Shenzhen Bao an Authentic TCM Therapy Hospital   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

^d THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Acupuncture and moxibustion; Anxiety; Electroacupuncture; Nerve regeneration; Neural regeneration; NSFC grant; Primary unipolar depression; Selective serotonin reuptake inhibitor; Seroxat; Symptom checklist 90

Indexed keywords

PAROXETINE;

ACUPUNCTURE; ACUPUNCTURE NEEDLE; ADULT; ANTIDEPRESSANT ACTIVITY; ANXIETY; ARTICLE; DEPRESSION; ELECTROACUPUNCTURE; FEMALE; FOLLOW UP; HAMILTON SCALE; HEADACHE; HOSTILITY; HUMAN; ICD-10; INSOMNIA; INTERPERSONAL SENSITIVITY SCORE; LOSS OF APPETITE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NAUSEA; PARANOIA; PHOBIA; PSYCHOSIS; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SOMATIZATION; SYMPTOM CHECKLIST 90; XEROSTOMIA;

EID: 84896336004     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.4103/1673-5374.125353     Document Type: Article

References (53)

1. Röschke J, Wolf C, Müller MJ, et al. The benefit from whole body acupuncture in major depression. J Affect Disord. 2000;57(1- 3):73-81.
2. Yeung AS, Ameral VE, Chuzi SE, et al. A pilot study of acupuncture augmentation therapy in antidepressant partial and non-responders with major depressive disorder. J Affect Disord. 2011;130(1- 2):285-289.
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Washington DC: American Psychiatric Press. 1994.
4. Zhang ZJ, Chen HY, Yip KC, et al. The effectiveness and safety of acupuncture therapy in depressive disorders: systematic review and meta-analysis. J Affect Disord. 2010;124(1-2):9-21.
5. Lecrubier Y. Widespread underrecognition and undertreatment of anxiety and mood disorders: results from 3 European studies. J Clin Psychiatry. 2007;68 Suppl 2:36-41.
6. Sartorius N, Baghai TC, Baldwin DS, et al. Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence. Int J Neuropsychopharmacol. 2007;10 Suppl 1:S1-207.
7. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6(4):278-296.
8. Faries D, Herrera J, Rayamajhi J, et al. The responsiveness of the Hamilton Depression Rating Scale. J Psychiatr Res. 2000;34(1):3-10.
9. Zung WW. A self-rating depression scale. Arch Gen Psychiatry. 1965;12:63-70.
10. William Guy. ECDEU Assessment Manual for Psychopharmacology. Rockville: U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs. 1976.
11. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-389.
12. Derogatis LR, Lipman RS, Rickels K, et al. The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci. 1974;19(1):1-15.
13. Pincus HA, Zarin DA, Tanielian TL, et al. Psychiatric patients and treatments in 1997: findings from the American Psychiatric Practice Research Network. Arch Gen Psychiatry. 1999;56(5):441-449.
14. Hasin DS, Goodwin RD, Stinson FS, et al. Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry. 2005;62(10):1097-1106.
15. Patten SB, Barbui C. Drug-induced depression: a systematic review to inform clinical practice. Psychother Psychosom. 2004;73(4):207-215.
16. Grunhaus L, Rabin D, Greden JF. Simultaneous panic and depressive disorder: response to antidepressant treatments. J Clin Psychiatry. 1986;47(1):4-7.
17. Ostacher MJ, Huffman J, Perlis R, eds. Evidence-based Pharmacotherapy of Major Depressive Disorder. Cambridge: Cambridge University Press. 2005.
18. Peretti S, Judge R, Hindmarch I. Safety and tolerability considerations: tricyclic antidepressants vs. selective serotonin reuptake inhibitors. Acta Psychiatr Scand Suppl. 2000;403:17-25.
19. Germann D, Ma G, Han F, et al. Paroxetine hydrochloride. Profiles Drug Subst Excip Relat Methodol. 2013;38:367-406.
20. Ferguson JM. SSRI Antidepressant Medications: Adverse Effects and Tolerability. Prim Care Companion J Clin Psychiatry. 2001;3(1):22-27.
21. Vander Watt G, Laugharne J, Janca A. Complementary and alternative medicine in the treatment of anxiety and depression. Curr Opin Psychiatry. 2008;21(1):37-42.
22. Wu J, Yeung AS, Schnyer R, et al. Acupuncture for depression: a review of clinical applications. Can J Psychiatry. 2012;57(7):397-405.
23. Schnyer RA, Flaws B. Curing Depression Naturally: With Chinese Medicine. Boulder: Blue Poppy Press. 2007.
24. Zhu ZH, Ding Z. Acupuncture and moxibustion treatment of anxiety neurosis and study on characteristics of acupoint selection. Zhongguo Zhen Jiu. 2008;28(7):545-548.
25. Huang QF. Exploration of the clinical regularity of acupuncture- moxibustion treatment for depression. Zhenjiu Tuina Yixue: Yingwen Ban. 2009;7(1):57-60.
26. Acar HV, Cuvaş O, Ceyhan A, et al. Acupuncture on yintang point decreases preoperative anxiety. J Altern Complement Med. 2013;19(5):420-424.
27. You W, Shi YJ, Han YJ, et al. Effect of electroacupuncture of "Baihui" (GV 20)-"Yintang" (EX-HN 3) on the expression of glucocorticoid and glucocorticoid receptor mRNA of the chronic stress model rats. Zhen Ci Yan Jiu. 2010;35(4):261-266.
28. Zheng Y, Qu S, Wang N, et al. Post-stimulation effect of electroacupuncture at Yintang (EX-HN3) and GV20 on cerebral functional regions in healthy volunteers: a resting functional MRI study. Acupunct Med. 2012;30(4):307-315.
29. Wang Y, Hu YP, Wang WC, et al. Clinical studies on treatment of earthquake-caused posttraumatic stress disorder using electroacupuncture. Evid Based Complement Alternat Med. 2012;2012:431279.
30. Jiang JF, Xu L, Lin YH, et al. Anti-depression effect of acupuncture and moxibustion based on SSRIs medication. Zhongguo Zhen Jiu. 2012;32(3):219-223.
31. Sun H, Zhao H, Ma C, et al. Effects of Electroacupuncture on Depression and the Production of Glial Cell Line-Derived Neurotrophic Factor Compared with Fluoxetine: A Randomized Controlled Pilot Study. J Altern Complement Med. in press.
32. Sun H, Zhao H, Zhang J, et al. Effect of acupuncture at Baihui (GV 20) and Zusanli (ST 36) on the level of serum inflammatory cytokines in patients with depression. Zhongguo Zhen Jiu. 2010;30(3): 195-199.
33. Chen XH, Li Y, Kui Y, et al. Sleep disorder treated mainly with flying needling therapy: a clinical randomized controlled research. Zhongguo Zhen Jiu. 2013;33(2):97-100.
34. He QY, Liang J, Zhang Y, et al. Thirty-two subjects of vascular headache treated by acupuncture combined with Chinese herbal decoction. J Tradit Chin Med. 2009;29(4):253-257.
35. Pi M, Luo WS, Diao LH, et al. Electroacupuncture at Du channel and meridian of foot-Taiyang for hippocampal neurons in rats with depression. Neural Regen Res. 2007;2(6):365-368.
36. Guo LK, Zhang CX, Guo XF. Acupuncture combined with Chinese herbal medicine Plantain and Senna Granule in treatment of functional constipation: a randomized, controlled trial. Zhong Xi Yi Jie He Xue Bao. 2011;9(11):1206-1214.
37. Peng DH, Fang YR. Clinical and pathogenesis researches on depressive disorder in China. Shanghai Jiaotong Daxue Xuebao: Yixue Ban. 2010;30(6):609-611.
38. LeDoux JE. Emotion circuits in the brain. Annu Rev Neurosci. 2000;23:155-184.
39. Spoont MR. Modulatory role of serotonin in neural information processing: implications for human psychopathology. Psychol Bull. 1992;112(2):330-350.
40. Watanabe A, Hasegawa S, Nishi K, et al. Chronic buspirone treatment normalizes regional serotonin synthesis in the olfactory bulbectomized rat brain: an autoradiographic study. Brain Res Bull. 2006;69(2):101-108.
41. Vaidya VA, Siuciak JA, Du F, et al. Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures. Neuroscience. 1999;89(1):157-166.
42. Malberg JE, Eisch AJ, Nestler EJ, et al. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci. 2000;20(24):9104-9110.
43. Sairanen M, O'Leary OF, Knuuttila JE, et al. Chronic antidepressant treatment selectively increases expression of plasticity-related proteins in the hippocampus and medial prefrontal cortex of the rat. Neuroscience. 2007;144(1):368-374.
44. Brunello N, Mendlewicz J, Kasper S, et al. The role of noradrenaline and selective noradrenaline reuptake inhibition in depression. Eur Neuropsychopharmacol. 2002;12(5):461-475.
45. Nutt DJ. The neuropharmacology of serotonin and noradrenaline in depression. Int Clin Psychopharmacol. 2002;17 Suppl 1:S1-12.
46. Zhang JB, Wang LL, Lv M, et al. Effects of acupuncture on monoamine neurotransmitter in frontal cortex of depressed model rats. Zhongguo Linchuang Kangfu. 2006;10(15):129-131.
47. Fu WB, Liu JH, Bai YF, et al. Effect of electroacupuncture on CREB-BDNF postreceptor signal transduction pathway in hippocampus of depression rats. Zhongguo Laonian Xue Zazhi. 2009;29(23):3038-3042.
48. Chen HD, Jin LQ, Lou R, et al. Effect of electroacupuncture and catgut embedding at point Baihui on behaviors and serum CORT and ACTH in a rat model of chronic stress-induced depression. Shanghai Zhenjiu Zazhi. 2010;29(4):244-247.
49. World Health Organization Geneva. The ICD-10 Classification of Mental and Behavioural Disorders. Geneva: WHO. 1993.
50. Leucht S, Fennema H, Engel R, et al. What does the HAMD mean? J Affect Disord. 2013;148(2-3):243-248.
51. Boyer WF, Feighner JP. An overview of paroxetine. J Clin Psychiatry. 1992;53 Suppl:3-6.
52. The World Federation of Acupuncture-Moxibustion Societies. GB 12346-90 Location of Points. Beijing: WFAS. 2007.
53. Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ. 1999;319(7211):670-674.